Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Floreane Medical Implants was a French medical technology company specializing in the development and manufacture of innovative surgical mesh implants for soft tissue repair. The company's product portfolio addressed a wide range of clinical needs, including hernia repair, pelvic floor reconstruction, urinary incontinence, and adhesion prevention. Founded in the 1990s, Floreane became a leader in the field of synthetic and composite meshes, notably through its subsidiary Sofradim Production. In 2005-2006, the company was acquired by Tyco Healthcare (which later became Covidien and is now part of Medtronic) for approximately $145 million. Its technologies and manufacturing facilities in Trévoux, France, continue to be a core part of Medtronic's global hernia and surgical solutions business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Floreane Medical Implants.